Profil
Dr. Andrew Saunders, MD, is a Chief Medical Officer at Captor Therapeutics SA and a Chief Medical Officer at CellCentric Ltd. Dr. Saunders was previously employed as a Chief Medical Officer by Redx Pharma Plc, a Chief Medical Officer by Lytix Biopharma AS, a Chief Medical Officer by Bioenvision, Inc., and a Managing Director by Linden Oncology Ltd. He received his doctorate degree from Trinity College Dublin.
Postes actifs de Andrew Saunders
| Sociétés | Poste | Début |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Directeur Technique/Scientifique/R&D | 01/03/2024 |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule inhibitors for cancer | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Andrew Saunders
| Sociétés | Poste | Fin |
|---|---|---|
| REDX PHARMA LTD | Directeur Technique/Scientifique/R&D | 01/03/2021 |
| LYTIX BIOPHARMA ASA | Directeur Technique/Scientifique/R&D | 01/12/2017 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Directeur Technique/Scientifique/R&D | 09/04/2007 |
Linden Oncology Ltd. | Directeur Général | - |
Formation de Andrew Saunders
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Trinity College Dublin
Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule inhibitors for cancer | Health Technology |
Lytix Biopharma AS
Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Redx Pharma Plc
Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Linden Oncology Ltd. | |
Captor Therapeutics SA
Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
















